CVS Health Corporation (CVS)

CVS Health Corp.'s stock price has been impacted by several events. The company's stock rose by 2.23% after it raised its 2025 revenue guidance and presented a multi-year growth plan at its Investor Day. A new economic impact report was released, but the stock experienced a 1.46% decline. Investor concerns arose due to a proposed minimal increase of just 0.09% in Medicare Advantage rates for 2027, which could significantly impact CVS's healthcare benefits segment, Aetna. CVS's decision to exit Horizon NJ Medicaid was highlighted, raising questions about the balance between reimbursement terms and maintaining access to Medicaid customers, potentially affecting script volumes in New Jersey.

CVS Health Corp. experiences demand seasonality within its Pharmacy and Consumer Wellness segment. This segment benefits from seasonal trends, including increased demand for vaccines and a longer flu season, which contributed to an 11.1% year-over-year revenue growth in the first quarter of 2025. The company actively promotes seasonal flu and immunization awareness to leverage these periods of heightened demand.

CVS Health Corp. is a diversified healthcare company with operations in retail pharmacy, pharmacy benefits management (PBM), health insurance, and walk-in medical clinics. The company provides accessible, affordable, and high-quality care across the United States. Its primary industries are managed healthcare, health insurance, and pharmacy. Major products and services include CVS Pharmacy, CVS Caremark, Aetna, and MinuteClinic. The company also operates Omnicare and Navarro Discount Pharmacies, and offers branded and generic prescription drugs, cosmetics, groceries, nonprescription medicines, personal health supplies, and vitamins.

CVS Health Corp. primarily operates within the United States, with approximately 9,000 retail locations and over 1,000 walk-in and primary care medical clinics across all 50 states, the District of Columbia, and Puerto Rico. Its headquarters are in Woonsocket, Rhode Island, with additional key regional and administrative offices in cities such as Irving, Texas; Northbrook, Illinois; Pittsburgh, Pennsylvania; Boston, Massachusetts; Hartford, Connecticut; Chicago, Illinois; and Scottsdale, Arizona.

Aetna, a CVS Health company, received the inaugural "Health Plan of the Year Award" from Press Ganey on February 5, 2026, recognizing its sustained performance and member-focused approach.

Institutional investors hold a significant portion of CVS Health Corp. shares, with approximately 76% to 88% of the company's shares owned by institutional investors. Major institutional shareholders include Vanguard Group Inc., BlackRock, Inc., Dodge & Cox, Capital World Investors, State Street Corp, JPMorgan Chase & Co., and Invesco Ltd. Individual investors and public companies own the remaining shares.